Armando Blanco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Armando Blanco has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Cano
University of Granada
7 shared publications - Francisco J Lopez
Department of Computer Science and Artificial Intelligence, University of Granada, Granada, Spain
3 shared publications - Marta Cuadros
GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
3 shared publications Carlos Cano
Department of Computer Science and Artificial Intelligence, University of Granada, Granada
2 shared publications- Carmen Navarro
Science for Life Laboratory, Karolinska Institutet, Department of Medical Biochemistry and Biophysics, Division of Genome Biology
2 shared publications - Fernando Garcia
Department of Computer Science and Artificial Intelligence, University of Granada, Granada 18071, Spain
2 shared publications
Latest Publications
- Open Access
- 4 March 2022
- Published by Springer Nature in BMC Medical Genomics
- Vol. 15 (1) , 1-7
Acceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers
Background: DNA methylation (DNAm) age metrics have been widely accepted as an epigenetic biomarker for biological aging and disease. The purpose of this study is to assess whether or not individuals carrying Lynch Syndrome-associated mutations are affected in their rate of biological aging, as measured by the epigenetic clock. Methods: Genome-wide bisulfite DNA sequencing data were generated using DNA from CD4 + T-cells obtained from peripheral blood using 27 patient samples from Lynch syndrome families. Horvath’s DNAm age model based on penalized linear regression was applied to estimate DNAm age from patient samples with distinct clinical and genetic characteristics to investigate cancer mutation-related aging effects. Results: Both Lynch mutation carriers and controls exhibited high variability in their estimated DNAm age, but regression analysis showed steeper slope for the Lynch mutation carriers. Remarkably, six Lynch Syndrome-associated mutation carriers showed a strong correlation to the control group, and two sisters carrying Lynch Syndrome-associated mutations, with no significant difference in lifestyle and similar chronological age, were assigned very different DNAm age. Conclusions: Future studies will be required to explore, in larger patient populations, whether specific epigenetic age acceleration is predictive of time-to-cancer development, treatment response, and survival. Epigenetic clock DNAm metrics may be affected by the presence of cancer mutations in the germline, and thus show promise of potential clinical utility for stratified surveillance strategies based on the relative risk for imminent emergence of tumor lesions in otherwise healthy Lynch Syndrome-associated mutation carriers.
- 4 March 2022
- Published by Springer Nature in BMC Medical Genomics
- Vol. 15 (1) , 1-7
Open AccessAcceleration of the DNA methylation clock among lynch syndrome-associated mutation carriers
Background: DNA methylation (DNAm) age metrics have been widely accepted as an epigenetic biomarker for biological aging and disease. The purpose of this study is to assess whether or not individuals carrying Lynch Syndrome-associated mutations are affected in their rate of biological aging, as measured by the epigenetic clock. Methods: Genome-wide bisulfite DNA sequencing data were generated using DNA from CD4 + T-cells obtained from peripheral blood using 27 patient samples from Lynch syndrome families. Horvath’s DNAm age model based on penalized linear regression was applied to estimate DNAm age from patient samples with distinct clinical and genetic characteristics to investigate cancer mutation-related aging effects. Results: Both Lynch mutation carriers and controls exhibited high variability in their estimated DNAm age, but regression analysis showed steeper slope for the Lynch mutation carriers. Remarkably, six Lynch Syndrome-associated mutation carriers showed a strong correlation to the control group, and two sisters carrying Lynch Syndrome-associated mutations, with no significant difference in lifestyle and similar chronological age, were assigned very different DNAm age. Conclusions: Future studies will be required to explore, in larger patient populations, whether specific epigenetic age acceleration is predictive of time-to-cancer development, treatment response, and survival. Epigenetic clock DNAm metrics may be affected by the presence of cancer mutations in the germline, and thus show promise of potential clinical utility for stratified surveillance strategies based on the relative risk for imminent emergence of tumor lesions in otherwise healthy Lynch Syndrome-associated mutation carriers.
- 25 March 2016
- Published by Springer Nature
- p. 781-789
A Mechanistic Study of lncRNA Fendrr Regulation of FoxF1 Lung Cancer Tumor Supressor
- 25 March 2016
- Published by Springer Nature
- p. 781-789
A Mechanistic Study of lncRNA Fendrr Regulation of FoxF1 Lung Cancer Tumor Supressor
- 1 January 2015
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 63 (1) , 41-49
DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
- 1 January 2015
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 63 (1) , 41-49
DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
- Open Access
- 10 January 2014
- Published by Springer Nature in BMC Bioinformatics
- Vol. 15 (S1) , S5
ProphNet: A generic prioritization method through propagation of information
Prioritization methods have become an useful tool for mining large amounts of data to suggest promising hypotheses in early research stages. Particularly, network-based prioritization tools use a network representation for the interactions between different biological entities to identify novel indirect relationships. However, current network-based prioritization tools are strongly tailored to specific domains of interest (e.g. gene-disease prioritization) and they do not allow to consider networks with more than two types of entities (e.g. genes and diseases). Therefore, the direct application of these methods to accomplish new prioritization tasks is limited.
- 10 January 2014
- Published by Springer Nature in BMC Bioinformatics
- Vol. 15 (S1) , S5
Open AccessProphNet: A generic prioritization method through propagation of information
Prioritization methods have become an useful tool for mining large amounts of data to suggest promising hypotheses in early research stages. Particularly, network-based prioritization tools use a network representation for the interactions between different biological entities to identify novel indirect relationships. However, current network-based prioritization tools are strongly tailored to specific domains of interest (e.g. gene-disease prioritization) and they do not allow to consider networks with more than two types of entities (e.g. genes and diseases). Therefore, the direct application of these methods to accomplish new prioritization tasks is limited.
- Open Access
- 9 November 2012
- Published by EMBnet Stichting in EMBnet.Journal
- Vol. 18 (B) , 74-76
DiGSNP: a web tool for Disease-Gene-SNP hierarchical prioritization
Motivation and Objectives Understanding the genetic causes of human diseases is the major goal towards an effective personalized medicine. High-throughput technologies such as linkage analysis, association studies and array experiments allow to obtain experimental evidence of chromosomal regions associated with phenotypes. However, these technologies typically report a large number of results (i.e. genes, variants, etc.) associated with the conditions under study. In this context, tools supporting researchers in the process of prioritizing diseases, genes, and variations are highly desired to assist the scientific research and provide guidance on the most promising hypotheses. To this end, many gene-disease prioritization methods have been proposed in the literature (Moreau and Tranchevent, 2012). These methods describe computational approaches that use information retrieved from diverse sources in order to obtain prioritized lists of candidate genes to be related with a certain target disease. However, most of these tools do not consider gene variations, although they are known to be the main cause for many diseases. Proposals like AnnTools (Makarov et al., 2012) or SNPRank (Jadamba et al., 2012), based in genome-wide association studies (GWAS), relate variations directly to diseases, but leave gene-disease information out or implicit. Moreover, most currently available tools for associating genome variations to diseases focus on coding regions, disregarding relevant information present in the promoter regions of genes, such as variations that alter the binding affinity of transcription factor binding sites (TFBS), which have been shown to play an important role in the regulatory machinery of the cell. In this work we present DiGSNP (Disease-Gene-SNP Prioritizer), a tool which allows to relate diseases, genes and variations in regulatory regions of the genome (particularly, those affecting TFBSs), simultaneously, helping researchers to understand how these relations work and focus on the most relevant regulatory elements in the early research stage of any disease. Methods DiGSNP prioritizer searches for relations between diseases, genes and variations in a two-level hierarchy. The first level builds an ordered list of genes related to a query disease. The second level adds a list of single-nucleotide polymorphisms (SNP) present in TFBSs in the regulatory regions of each gene (i.e. building a Disease-gene-SNP hierarchy), prioritized by the expected level of influence in the binding affinity of the TFBS. Disease-gene prioritization method is based on ProphNet (Martinez et al., 2012, http://genome2.ugr.es/prophnet/ ). This method allows to prioritize biological entities from different domains (e.g. genes, diseases, protein domains) by integrating an arbitrary amount of heterogeneous sources of data represented as networks. The resultant super-graph is then mined using a Random Walk with Restart (RWR) algorithm for obtaining prioritized lists of elements associated to the user query. We have applied the ProphNet algorithm to obtain prioritized lists of genes for a query disease. The algorithm was applied on a network composed of three different types of nodes: genes/proteins, phenotypes and protein domains. The phenotype network and the phenotype-gene connections were extracted from OMIM using text-mining techniques; the gene network was obtained from the Human Protein Reference Database (HPRD, http://www.hprd.org/) and the protein domain network was derived from DOMINE and InterDom (http://interdom.i2r.a-star.edu.sg/), with the domain-gene and domain-phenotype relationships extracted from Pfam (http://pfam.sanger.ac.uk/). After obtaining a prioritized list of genes related to the query disease, each gene is associated to a list of SNPs present in its promoter regions. SNPs are obtained from dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/). Gene-SNP prioritization is applied to each SNP list based on two criteria. First, SNPs located in a TFBS are candidate regulatory SNPs. Second, a SNP that causes drastic changes in the binding affinity of a TFBS has a higher probability to affect the gene regulation and therefore to be related to the query disorder. In order to assess whether a SNP is located in a known TFBS, SCintuit (García-Alcalde et al., 2010), a sequence-motif similarity measure, is used. SCintuit applies intuitionistic theory, an extension of fuzzy theory, to generate a similarity score. Motif information is retrieved from Jaspar (http://jaspar.cgb.ki.se/) and TRANSFAC. According to the mentioned two criteria, DiGSNP reduces the set of SNPs in regulatory regions of the gene to a set of SNPs located in a site matching a TFBS, i.e. sites showing a SCintuit similarity score to a known TFBS above a provided threshold. Selected SNPs are ordered depending on the difference of similarity between the mutated and wild-type alleles. Therefore, SNPs that dramatically alter the binding affinity of a TFBS are ranked at the top by DiGSNP. Integrating these two prioritization methods, we offer an approach to disease-gene-SNP prioritization. In table 1, a summary result relating Alzheimer disease to a list of prioritized genes and each gene relating to a list of prioritized SNPs is shown. This way of structuring the information allows the user to visually infer possible relations among genes, diseases, SNPs and TFBSs. For instance, the frequent appearance of motif Kid3 as best result in many SNPs reveals a direct relation of Kid3 and Alzheimer (Acquaah-Mensah et al., 2012), which would have been otherwise difficult to discover. Results and Discussion The proposed methodology can be applied to any prioritization method that can score genes relating to diseases and SNPs related to genes. Due to the lack of information sources relating regulatory variations and diseases, validation becomes a difficult process, along with determining the biological impact of the results obtained. Relations between genes in Table 1 such as APP, TREM1 and TREM2 and Alzheimer disease can be found in the literature (Cruchaga et al. 2012). However, finding information in the literature about the SNPs that appear in table 1 was not possible. The main reason is probably that the focus of research relating to SNPs has relied on coding regions, searching for missense variations in exomic areas of the genome. Our main focus is transcriptional regulation, area from which the amount of available information is much less significant. Moreover, other tools, like SNPRank (Jadamba et al., 2012), focus on coding areas of the genome. This makes it unfeasible to compare the results, since the sets of SNPs obtained should always be different. Other approaches like regSNPs (Teng et al. 2012) focus on regulatory elements, but require experimental evidence from a GWAS and make an inverse process, starting from variations proven to be related to a disease by GWAS results. Furthermore, these tools relate directly diseases and variations, leaving gene information out or implicit. We believe that DiGSNP can be helpful to researchers, who can see in a glance the relationship between a certain disease and a set of SNPs related to genes, probably involved in the regulation processes that affect the target disease. In addition, the second step of DiGSNP focuses on genomic information and our knowledge about TFBSs and their binding affinity, making it possible for researchers to obtain a set of probable candidates for any disease. Evidence of variation-disease association in the literature is not needed for placing a query in DiGSNP. This feature makes DiGSNP a helpful tool when trying to discover a set of highly related SNPs and genes to a new query disease to boost further research. Acknowledgements This work has been carried out as part of projects P08-TIC-4299 of J. A., Sevilla and TIN2009-13489 of DGICT, Madrid References Acquaah-Mensah GK, Taylor RC, et al. (2012) PACAP interactions in the mouse brain: implications for behavioral and other disorders. Gene, 491(2):224-231. doi:10.1016/j.gene.2011.09.017. Cruchaga C, Chakraverty S, et al. (2012). Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer’s Disease Families. PLoS One 7(2). doi:10.1371/journal.pone.0031039 García-Alcalde F, Blanco A, et al. (2010). An intuitionistic approach to scoring DNA sequences against transcription factor binding site motifs. BMC bioinformatics, 11(1): 551. doi:10.1186/1471-2105-11-551. Jadamba E, Shin M. (2012). A SNP Prioritization Method Using Linkage Disequilibrium Network for Disease Association Study. INTELLI 2012 (c), 86-88. Makarov V, O’Grady T, et al. (2012). AnnTools: a comprehensive and versatile annotation toolkit for genomic variants. Bioinformatics, 28(5):724-5. doi:10.1093/bioinformatics/bts032 Martinez V, Cano C, et al. (2012). Network-based gene-disease prioritization using ProphNet. EMBnet.journal S18.B (in press) Moreau Y and Tranchevent LC (2012). Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nature Reviews Genetics 13:523-536. doi:10.1038/nrg3253 Note: Figures and tables are available in PDF version only.
- 9 November 2012
- Published by EMBnet Stichting in EMBnet.Journal
- Vol. 18 (B) , 74-76
Open AccessDiGSNP: a web tool for Disease-Gene-SNP hierarchical prioritization
Motivation and Objectives Understanding the genetic causes of human diseases is the major goal towards an effective personalized medicine. High-throughput technologies such as linkage analysis, association studies and array experiments allow to obtain experimental evidence of chromosomal regions associated with phenotypes. However, these technologies typically report a large number of results (i.e. genes, variants, etc.) associated with the conditions under study. In this context, tools supporting researchers in the process of prioritizing diseases, genes, and variations are highly desired to assist the scientific research and provide guidance on the most promising hypotheses. To this end, many gene-disease prioritization methods have been proposed in the literature (Moreau and Tranchevent, 2012). These methods describe computational approaches that use information retrieved from diverse sources in order to obtain prioritized lists of candidate genes to be related with a certain target disease. However, most of these tools do not consider gene variations, although they are known to be the main cause for many diseases. Proposals like AnnTools (Makarov et al., 2012) or SNPRank (Jadamba et al., 2012), based in genome-wide association studies (GWAS), relate variations directly to diseases, but leave gene-disease information out or implicit. Moreover, most currently available tools for associating genome variations to diseases focus on coding regions, disregarding relevant information present in the promoter regions of genes, such as variations that alter the binding affinity of transcription factor binding sites (TFBS), which have been shown to play an important role in the regulatory machinery of the cell. In this work we present DiGSNP (Disease-Gene-SNP Prioritizer), a tool which allows to relate diseases, genes and variations in regulatory regions of the genome (particularly, those affecting TFBSs), simultaneously, helping researchers to understand how these relations work and focus on the most relevant regulatory elements in the early research stage of any disease. Methods DiGSNP prioritizer searches for relations between diseases, genes and variations in a two-level hierarchy. The first level builds an ordered list of genes related to a query disease. The second level adds a list of single-nucleotide polymorphisms (SNP) present in TFBSs in the regulatory regions of each gene (i.e. building a Disease-gene-SNP hierarchy), prioritized by the expected level of influence in the binding affinity of the TFBS. Disease-gene prioritization method is based on ProphNet (Martinez et al., 2012, http://genome2.ugr.es/prophnet/ ). This method allows to prioritize biological entities from different domains (e.g. genes, diseases, protein domains) by integrating an arbitrary amount of heterogeneous sources of data represented as networks. The resultant super-graph is then mined using a Random Walk with Restart (RWR) algorithm for obtaining prioritized lists of elements associated to the user query. We have applied the ProphNet algorithm to obtain prioritized lists of genes for a query disease. The algorithm was applied on a network composed of three different types of nodes: genes/proteins, phenotypes and protein domains. The phenotype network and the phenotype-gene connections were extracted from OMIM using text-mining techniques; the gene network was obtained from the Human Protein Reference Database (HPRD, http://www.hprd.org/) and the protein domain network was derived from DOMINE and InterDom (http://interdom.i2r.a-star.edu.sg/), with the domain-gene and domain-phenotype relationships extracted from Pfam (http://pfam.sanger.ac.uk/). After obtaining a prioritized list of genes related to the query disease, each gene is associated to a list of SNPs present in its promoter regions. SNPs are obtained from dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/). Gene-SNP prioritization is applied to each SNP list based on two criteria. First, SNPs located in a TFBS are candidate regulatory SNPs. Second, a SNP that causes drastic changes in the binding affinity of a TFBS has a higher probability to affect the gene regulation and therefore to be related to the query disorder. In order to assess whether a SNP is located in a known TFBS, SCintuit (García-Alcalde et al., 2010), a sequence-motif similarity measure, is used. SCintuit applies intuitionistic theory, an extension of fuzzy theory, to generate a similarity score. Motif information is retrieved from Jaspar (http://jaspar.cgb.ki.se/) and TRANSFAC. According to the mentioned two criteria, DiGSNP reduces the set of SNPs in regulatory regions of the gene to a set of SNPs located in a site matching a TFBS, i.e. sites showing a SCintuit similarity score to a known TFBS above a provided threshold. Selected SNPs are ordered depending on the difference of similarity between the mutated and wild-type alleles. Therefore, SNPs that dramatically alter the binding affinity of a TFBS are ranked at the top by DiGSNP. Integrating these two prioritization methods, we offer an approach to disease-gene-SNP prioritization. In table 1, a summary result relating Alzheimer disease to a list of prioritized genes and each gene relating to a list of prioritized SNPs is shown. This way of structuring the information allows the user to visually infer possible relations among genes, diseases, SNPs and TFBSs. For instance, the frequent appearance of motif Kid3 as best result in many SNPs reveals a direct relation of Kid3 and Alzheimer (Acquaah-Mensah et al., 2012), which would have been otherwise difficult to discover. Results and Discussion The proposed methodology can be applied to any prioritization method that can score genes relating to diseases and SNPs related to genes. Due to the lack of information sources relating regulatory variations and diseases, validation becomes a difficult process, along with determining the biological impact of the results obtained. Relations between genes in Table 1 such as APP, TREM1 and TREM2 and Alzheimer disease can be found in the literature (Cruchaga et al. 2012). However, finding information in the literature about the SNPs that appear in table 1 was not possible. The main reason is probably that the focus of research relating to SNPs has relied on coding regions, searching for missense variations in exomic areas of the genome. Our main focus is transcriptional regulation, area from which the amount of available information is much less significant. Moreover, other tools, like SNPRank (Jadamba et al., 2012), focus on coding areas of the genome. This makes it unfeasible to compare the results, since the sets of SNPs obtained should always be different. Other approaches like regSNPs (Teng et al. 2012) focus on regulatory elements, but require experimental evidence from a GWAS and make an inverse process, starting from variations proven to be related to a disease by GWAS results. Furthermore, these tools relate directly diseases and variations, leaving gene information out or implicit. We believe that DiGSNP can be helpful to researchers, who can see in a glance the relationship between a certain disease and a set of SNPs related to genes, probably involved in the regulation processes that affect the target disease. In addition, the second step of DiGSNP focuses on genomic information and our knowledge about TFBSs and their binding affinity, making it possible for researchers to obtain a set of probable candidates for any disease. Evidence of variation-disease association in the literature is not needed for placing a query in DiGSNP. This feature makes DiGSNP a helpful tool when trying to discover a set of highly related SNPs and genes to a new query disease to boost further research. Acknowledgements This work has been carried out as part of projects P08-TIC-4299 of J. A., Sevilla and TIN2009-13489 of DGICT, Madrid References Acquaah-Mensah GK, Taylor RC, et al. (2012) PACAP interactions in the mouse brain: implications for behavioral and other disorders. Gene, 491(2):224-231. doi:10.1016/j.gene.2011.09.017. Cruchaga C, Chakraverty S, et al. (2012). Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer’s Disease Families. PLoS One 7(2). doi:10.1371/journal.pone.0031039 García-Alcalde F, Blanco A, et al. (2010). An intuitionistic approach to scoring DNA sequences against transcription factor binding site motifs. BMC bioinformatics, 11(1): 551. doi:10.1186/1471-2105-11-551. Jadamba E, Shin M. (2012). A SNP Prioritization Method Using Linkage Disequilibrium Network for Disease Association Study. INTELLI 2012 (c), 86-88. Makarov V, O’Grady T, et al. (2012). AnnTools: a comprehensive and versatile annotation toolkit for genomic variants. Bioinformatics, 28(5):724-5. doi:10.1093/bioinformatics/bts032 Martinez V, Cano C, et al. (2012). Network-based gene-disease prioritization using ProphNet. EMBnet.journal S18.B (in press) Moreau Y and Tranchevent LC (2012). Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nature Reviews Genetics 13:523-536. doi:10.1038/nrg3253 Note: Figures and tables are available in PDF version only.
- 24 May 2012
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 50 (9) , 981-990
Biomedical application of fuzzy association rules for identifying breast cancer biomarkers
Current breast cancer research involves the study of many different prognosis factors: primary tumor size, lymph node status, tumor grade, tumor receptor status, p53, and ki67 levels, among others. High-throughput microarray technologies are allowing to better understand and identify prognostic factors in breast cancer. But the massive amounts of data derived from these technologies require the use of efficient computational techniques to unveil new and relevant biomedical knowledge. Furthermore, integrative tools are needed that effectively combine heterogeneous types of biomedical data, such as prognosis factors and expression data. The objective of this study was to integrate information from the main prognostic factors in breast cancer with whole-genome microarray data to identify potential associations among them. We propose the application of a data mining approach, called fuzzy association rule mining, to automatically unveil these associations. This paper describes the proposed methodology and illustrates how it can be applied to different breast cancer datasets. The obtained results support known associations involving the number of copies of chromosome-17, HER2 amplification, or the expression level of estrogen and progesterone receptors in breast cancer patients. They also confirm the correspondence between the HER2 status predicted by different testing methodologies (immunohistochemistry and fluorescence in situ hybridization). In addition, other interesting rules involving CDC6, SOX11, and EFEMP1 genes are identified, although further detailed studies are needed to statistically confirm these findings. As part of this study, a web platform implementing the fuzzy association rule mining approach has been made freely available at: http://www.genome2.ugr.es/biofar.
- 24 May 2012
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 50 (9) , 981-990
Biomedical application of fuzzy association rules for identifying breast cancer biomarkers
Current breast cancer research involves the study of many different prognosis factors: primary tumor size, lymph node status, tumor grade, tumor receptor status, p53, and ki67 levels, among others. High-throughput microarray technologies are allowing to better understand and identify prognostic factors in breast cancer. But the massive amounts of data derived from these technologies require the use of efficient computational techniques to unveil new and relevant biomedical knowledge. Furthermore, integrative tools are needed that effectively combine heterogeneous types of biomedical data, such as prognosis factors and expression data. The objective of this study was to integrate information from the main prognostic factors in breast cancer with whole-genome microarray data to identify potential associations among them. We propose the application of a data mining approach, called fuzzy association rule mining, to automatically unveil these associations. This paper describes the proposed methodology and illustrates how it can be applied to different breast cancer datasets. The obtained results support known associations involving the number of copies of chromosome-17, HER2 amplification, or the expression level of estrogen and progesterone receptors in breast cancer patients. They also confirm the correspondence between the HER2 status predicted by different testing methodologies (immunohistochemistry and fluorescence in situ hybridization). In addition, other interesting rules involving CDC6, SOX11, and EFEMP1 genes are identified, although further detailed studies are needed to statistically confirm these findings. As part of this study, a web platform implementing the fuzzy association rule mining approach has been made freely available at: http://www.genome2.ugr.es/biofar.
- Open Access
- 8 January 2011
- Published by IntechOpen
Social and Semantic Web Technologies for the Text-to-Knowledge Translation Process in Biomedicine
Social and Semantic Web Technologies for the Text-to-Knowledge Translation Process in Biomedicine | InTechOpen, Published on: 2011-01-08. Authors: Carlos Cano, Alberto Labarga, Armando Blanco, et
- 8 January 2011
- Published by IntechOpen
Open AccessSocial and Semantic Web Technologies for the Text-to-Knowledge Translation Process in Biomedicine
Social and Semantic Web Technologies for the Text-to-Knowledge Translation Process in Biomedicine | InTechOpen, Published on: 2011-01-08. Authors: Carlos Cano, Alberto Labarga, Armando Blanco, et
- Open Access
- 8 November 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 551
An intuitionistic approach to scoring DNA sequences against transcription factor binding site motifs
Transcription factors (TFs) control transcription by binding to specific regions of DNA called transcription factor binding sites (TFBSs). The identification of TFBSs is a crucial problem in computational biology and includes the subtask of predicting the location of known TFBS motifs in a given DNA sequence. It has previously been shown that, when scoring matches to known TFBS motifs, interdependencies between positions within a motif should be taken into account. However, this remains a challenging task owing to the fact that sequences similar to those of known TFBSs can occur by chance with a relatively high frequency. Here we present a new method for matching sequences to TFBS motifs based on intuitionistic fuzzy sets (IFS) theory, an approach that has been shown to be particularly appropriate for tackling problems that embody a high degree of uncertainty.
- 8 November 2010
- Published by Springer Nature in BMC Bioinformatics
- Vol. 11 (1) , 551
Open AccessAn intuitionistic approach to scoring DNA sequences against transcription factor binding site motifs
Transcription factors (TFs) control transcription by binding to specific regions of DNA called transcription factor binding sites (TFBSs). The identification of TFBSs is a crucial problem in computational biology and includes the subtask of predicting the location of known TFBS motifs in a given DNA sequence. It has previously been shown that, when scoring matches to known TFBS motifs, interdependencies between positions within a motif should be taken into account. However, this remains a challenging task owing to the fact that sequences similar to those of known TFBSs can occur by chance with a relatively high frequency. Here we present a new method for matching sequences to TFBS motifs based on intuitionistic fuzzy sets (IFS) theory, an approach that has been shown to be particularly appropriate for tackling problems that embody a high degree of uncertainty.
- Open Access
- 20 July 2009
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 224
FISim: A new similarity measure between transcription factor binding sites based on the fuzzy integral
Regulatory motifs describe sets of related transcription factor binding sites (TFBSs) and can be represented as position frequency matrices (PFMs). De novo identification of TFBSs is a crucial problem in computational biology which includes the issue of comparing putative motifs with one another and with motifs that are already known. The relative importance of each nucleotide within a given position in the PFMs should be considered in order to compute PFM similarities. Furthermore, biological data are inherently noisy and imprecise. Fuzzy set theory is particularly suitable for modeling imprecise data, whereas fuzzy integrals are highly appropriate for representing the interaction among different information sources.
- 20 July 2009
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 224
Open AccessFISim: A new similarity measure between transcription factor binding sites based on the fuzzy integral
Regulatory motifs describe sets of related transcription factor binding sites (TFBSs) and can be represented as position frequency matrices (PFMs). De novo identification of TFBSs is a crucial problem in computational biology which includes the issue of comparing putative motifs with one another and with motifs that are already known. The relative importance of each nucleotide within a given position in the PFMs should be considered in order to compute PFM similarities. Furthermore, biological data are inherently noisy and imprecise. Fuzzy set theory is particularly suitable for modeling imprecise data, whereas fuzzy integrals are highly appropriate for representing the interaction among different information sources.
- Open Access
- 19 February 2008
- Published by Springer Nature in BMC Bioinformatics
- Vol. 9 (1) , 107
Fuzzy association rules for biological data analysis: A case study on yeast
Last years' mapping of diverse genomes has generated huge amounts of biological data which are currently dispersed through many databases. Integration of the information available in the various databases is required to unveil possible associations relating already known data. Biological data are often imprecise and noisy. Fuzzy set theory is specially suitable to model imprecise data while association rules are very appropriate to integrate heterogeneous data.
- 19 February 2008
- Published by Springer Nature in BMC Bioinformatics
- Vol. 9 (1) , 107
Open AccessFuzzy association rules for biological data analysis: A case study on yeast
Last years' mapping of diverse genomes has generated huge amounts of biological data which are currently dispersed through many databases. Integration of the information available in the various databases is required to unveil possible associations relating already known data. Biological data are often imprecise and noisy. Fuzzy set theory is specially suitable to model imprecise data while association rules are very appropriate to integrate heterogeneous data.